CFO
TWST icon

CVA Family Office’s Twist Bioscience TWST Stock Holding History

CVA Family Office’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24K Hold
12
– – ﹤0.01% 1607
2026
Q1 		$570 Buy
+12
New +$538 ﹤0.01% 1732
2025
Q2 		– Sell
-15
Closed -$589 – 1450
2025
Q1 		$589 Hold
15
– – ﹤0.01% 1195
2024
Q4 		$697 Hold
15
– – ﹤0.01% 1150
2024
Q3 		$678 Hold
15
– – ﹤0.01% 1128
2024
Q2 		$739 Buy
+15
New +$612 ﹤0.01% 1112

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

CVA Family Office's TWST Position: Q2 2026 in Review

CVA Family Office held its Twist Bioscience (TWST) position steady in Q2 2026 at 12 shares worth $1.24K. The position accounts for ﹤0.01% of the portfolio, ranked #1607.

CVA Family Office first reported a position in TWST in Q2 2024 and has held it in 6 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • CVA Family Office held 12 shares of Twist Bioscience worth $1.24K as of Q2 2026.
  • CVA Family Office left its Twist Bioscience share count unchanged in Q2 2026.
  • Twist Bioscience made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1607 holding.
  • CVA Family Office first reported a position in Twist Bioscience in Q2 2024 and has held it in 6 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.